MiR-1 can suppress the growth of ovarian cancer cells by targeting p-Akt, p-ERK1/2, p-Rb, and CDK4 in HO-8910PM cells and suppress c-Met expression, which shows its inhibitory effect [17]. Here, RB1 is linked to ovarian carcinoma.